Related Experiment Video
Updated: May 24, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
SUGP1 loss is the sole driver of SF3B1 hotspot mutant missplicing in cancer
Peiqi Xing1,2, Pedro Bak-Gordon3, Jindou Xie1,2,4
1National Genomics Data Center, China National Center for Bioinformation, Beijing, 100101, China.
Abstract:
SF3B1 is the most frequently mutated splicing factor in cancer. Mechanistically, such mutations cause missplicing by promoting aberrant 3' splice site usage; however, how this occurs remains controversial. To address this issue, we employed a computational screen of 600 splicing-related proteins to identify those whose reduced expression recapitulated mutant SF3B1 splicing dysregulation. Strikingly, our analysis revealed only two proteins whose loss reproduced this effect. Extending our previous findings, loss of the G-patch protein SUGP1 recapitulated almost all splicing defects induced by SF3B1 hotspot mutations. Unexpectedly, loss of the RNA helicase Aquarius (AQR) reproduced ~40% of these defects. However, we found that AQR knockdown caused significant SUGP1 missplicing and reduced protein levels, suggesting that AQR loss reproduced mutant SF3B1 splicing defects only indirectly. This study advances our understanding of missplicing caused by oncogenic SF3B1 mutations, and highlights the fundamental role of SUGP1 in this process.
Insights
Mutations in SF3B1 cause cancer missplicing. Our study reveals the G-patch protein SUGP1 is crucial, while RNA helicase AQR plays an indirect role in this process.
Area of Science:
- Molecular Biology
- Cancer Genetics
- RNA Splicing
Background:
- SF3B1 is the most frequently mutated splicing factor in cancer.
- Mutant SF3B1 causes missplicing by aberrant 3' splice site usage, but the mechanism is unclear.
Purpose of the Study:
- To identify proteins whose reduced expression mimics SF3B1 mutation-induced splicing defects.
- To elucidate the mechanism of missplicing caused by oncogenic SF3B1 mutations.
Main Methods:
- Computational screening of 600 splicing-related proteins.
- Assessing the impact of protein loss on SF3B1-associated splicing dysregulation.
Main Results:
- Loss of SUGP1 recapitulated most SF3B1 mutation-induced splicing defects.
- Loss of Aquarius (AQR) reproduced ~40% of defects, but indirectly via SUGP1 missplicing.
- SUGP1 is identified as a key mediator of SF3B1-driven missplicing.
Conclusions:
- SUGP1 plays a fundamental role in missplicing caused by oncogenic SF3B1 mutations.
- AQR's effect on SF3B1 splicing defects is secondary to its impact on SUGP1 levels.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
RNA Splicing
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

